يعرض 181 - 200 نتائج من 78,867 نتيجة بحث عن '(( 5 ((ppm decrease) OR (a decrease)) ) OR ((( 1 n decrease ) OR ( e point decrease ))))', وقت الاستعلام: 1.26s تنقيح النتائج
  1. 181
  2. 182
  3. 183
  4. 184

    Glucose depletion decreases SBPM. حسب David S. Tourigny (7224299)

    منشور في 2019
    "…Replenishment of glucose alone is sufficient to restore a significantly higher SBPM. No substrate 20min <i>versus</i> glucose and pyruvate P = 0.013; no substrate 20min <i>versus</i> no substrate 10min P = 0.003; glucose alone <i>versus</i> no substrate 20min P = 0.012; N = 4. …"
  5. 185
  6. 186

    FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. حسب Laura L. Stafman (6577184)

    منشور في 2019
    "…<p>(A) HuH6 cells (2.5 x 10<sup>6</sup> cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …"
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193
  14. 194
  15. 195
  16. 196

    DataSheet_1_Decreased expression of SCARA5 predicts a poor prognosis in melanoma using bioinformatics analysis.xlsx حسب Qinggan Ni (14835463)

    منشور في 2023
    "…Background<p>It has been established that the scavenger receptor class A member 5 (SCARA5) functions as a tumor suppressor gene in various cancer types. …"
  17. 197

    Table_5_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx حسب Xiao-yang Gong (13103400)

    منشور في 2022
    "…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …"
  18. 198
  19. 199
  20. 200